Source: Cardiovascular Drugs and Therapy. Unidades: FMRP, FORP
Subjects: ANGIOTENSINAS, METALOPROTEINASES, HIPERTENSÃO
ABNT
FONTANA, Vanessa et al. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, v. 26, n. 6, p. 511-519, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10557-012-6420-2. Acesso em: 17 out. 2024.APA
Fontana, V., Silva, P. S., Izidoro-Toledo, T. C., Biagi, C., Oliveira, E. B. de, Gerlach, R. F., & Tanus-Santos, J. E. (2012). Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, 26( 6), 511-519. doi:10.1007/s10557-012-6420-2NLM
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 out. 17 ] Available from: https://doi.org/10.1007/s10557-012-6420-2Vancouver
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 out. 17 ] Available from: https://doi.org/10.1007/s10557-012-6420-2